New Key Statistics Module, Z-Score and F-Score
SZSE:002550 Key Ratios
Market Cap ¥ M | 8,369.89 |
Enterprise Value ¥ M | 7,770.97 |
P/E(ttm) | 28.19 |
PE Ratio without NRI | 38.25 |
Forward PE Ratio | 21.59 |
Price/Book | 3.39 |
Price/Sales | 5.36 |
Price/Free Cash Flow | 16.40 |
Price/Owner Earnings | 37.96 |
Payout Ratio % | 0.70 |
Revenue (TTM) ¥ M | 1,555.00 |
EPS (TTM) ¥ | 0.23 |
Beneish M-Score | -3.08 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | 23.00 |
EV-to-EBIT | 23.27 |
EV-to-EBITDA | 23.27 |
PEG | -- |
Shares Outstanding M | 1,279.80 |
Net Margin (%) | 18.87 |
Operating Margin % | 16.48 |
Pre-tax Margin (%) | 21.37 |
Quick Ratio | 6.21 |
Current Ratio | 8.32 |
ROA % (ttm) | 10.77 |
ROE % (ttm) | 12.07 |
ROIC % (ttm) | 11.30 |
Dividend Yield % | 1.91 |
Altman Z-Score | 20.32 |
SZSE:002550 Number of Guru Trades
SZSE:002550 Volume of Guru Trades
Gurus Latest Trades with SZSE:002550
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:002550 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Changzhou Qianhong Biopharma Co Ltd Insider Transactions
No Available Data